Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Toh, ZQ, Anderson, J, Mazarakis, N, Neeland, M, Higgins, RA, Rautenbacher, K, Dohle, K, Nguyen, J, Overmars, I, Donato, C, et al.
Comparison of Seroconversion in Children and Adults With Mild COVID-19..
JAMA Netw Open
5(3)
:
e221313
2022
view publication
Saunders, T, Burgner, D, Ranganathan, S.
Identifying and preventing cardiovascular disease in patients with cystic fibrosis.
Nature Cardiovascular Research
1(3)
:
187 -188
2022
view publication
Nuotio, J, Laitinen, TT, Sinaiko, AR, Woo, JG, Urbina, EM, Jacobs, DR, Steinberger, J, Prineas, RJ, Sabin, MA, Burgner, DP, et al.
Obesity during childhood is associated with higher cancer mortality rate during adulthood: the i3C Consortium..
Int J Obes (Lond)
46(2)
:
393 -399
2022
view publication
Crick, DCP, Halligan, SL, Howe, LD, Lacey, RE, Khandaker, GM, Burgner, D, Herbert, A, Suderman, M, Anderson, EL, Fraser, A.
Associations between Adverse Childhood Experiences and the novel inflammatory marker glycoprotein acetyls in two generations of the Avon Longitudinal Study of Parents and Children birth cohort..
Brain Behav Immun
100:
112 -120
2022
view publication